JPY 1435.0
(0.99%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 2.26 Billion JPY | -0.13% |
2022 | 2.42 Billion JPY | -10.08% |
2021 | 2.23 Billion JPY | 40.64% |
2020 | 1.83 Billion JPY | 7.27% |
2019 | 1.69 Billion JPY | 4.28% |
2018 | 1.61 Billion JPY | 4.23% |
2017 | 1.54 Billion JPY | 8.1% |
2016 | 1.43 Billion JPY | 5.64% |
2015 | 1.34 Billion JPY | 6.48% |
2014 | 1.26 Billion JPY | 2.04% |
2013 | 1.24 Billion JPY | 11.48% |
2012 | 1.28 Billion JPY | -2.16% |
2011 | 1.13 Billion JPY | -6.74% |
2010 | 1.07 Billion JPY | -2.25% |
2009 | 1.15 Billion JPY | 8.03% |
2008 | 1.01 Billion JPY | 12.63% |
2007 | 946.84 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -3 Million JPY | -102.75% |
2023 Q1 | 102.95 Million JPY | -0.43% |
2023 Q2 | 160.98 Million JPY | 56.37% |
2023 Q3 | 1.55 Billion JPY | 864.02% |
2023 Q4 | 206.5 Million JPY | -86.69% |
2023 FY | - JPY | -0.13% |
2022 Q4 | 103.39 Million JPY | -93.4% |
2022 Q1 | 95.82 Million JPY | -43.06% |
2022 Q2 | 223.87 Million JPY | 133.62% |
2022 Q3 | 1.56 Billion JPY | 600.0% |
2022 FY | - JPY | -10.08% |
2021 Q1 | 443.11 Million JPY | 448.55% |
2021 Q3 | 1.39 Billion JPY | 356.05% |
2021 FY | - JPY | 40.64% |
2021 Q2 | 305.58 Million JPY | -31.04% |
2021 Q4 | 168.29 Million JPY | -87.92% |
2020 FY | - JPY | 7.27% |
2020 Q1 | -15.36 Million JPY | -120.74% |
2020 Q4 | 80.77 Million JPY | -93.34% |
2020 Q3 | 1.21 Billion JPY | 251.91% |
2020 Q2 | 344.44 Million JPY | 2341.19% |
2019 FY | - JPY | 4.28% |
2019 Q1 | 109.81 Million JPY | -9.85% |
2019 Q4 | 74.08 Million JPY | -92.26% |
2019 Q3 | 957.58 Million JPY | 191.84% |
2019 Q2 | 328.11 Million JPY | 198.8% |
2018 Q1 | 65.09 Million JPY | -60.95% |
2018 FY | - JPY | 4.23% |
2018 Q2 | 232.17 Million JPY | 256.68% |
2018 Q3 | 978.87 Million JPY | 321.61% |
2018 Q4 | 121.81 Million JPY | -87.56% |
2017 Q1 | 61.49 Million JPY | -62.76% |
2017 Q4 | 166.71 Million JPY | -80.7% |
2017 Q3 | 863.94 Million JPY | 287.3% |
2017 Q2 | 223.07 Million JPY | 262.77% |
2017 FY | - JPY | 8.1% |
2016 Q4 | 165.1 Million JPY | -80.21% |
2016 Q2 | 220.34 Million JPY | 2116.11% |
2016 Q1 | 9.94 Million JPY | -93.41% |
2016 FY | - JPY | 5.64% |
2016 Q3 | 834.37 Million JPY | 278.66% |
2015 Q3 | 754.2 Million JPY | 358.37% |
2015 Q4 | 150.9 Million JPY | -79.99% |
2015 FY | - JPY | 6.48% |
2015 Q1 | 59.37 Million JPY | -67.16% |
2015 Q2 | 164.54 Million JPY | 177.11% |
2014 Q4 | 180.83 Million JPY | -70.52% |
2014 Q3 | 613.38 Million JPY | 259.98% |
2014 FY | - JPY | 2.04% |
2014 Q1 | 17.39 Million JPY | -87.37% |
2014 Q2 | 170.39 Million JPY | 879.49% |
2013 Q3 | 594.94 Million JPY | 297.87% |
2013 Q4 | 137.75 Million JPY | -76.85% |
2013 Q2 | 149.53 Million JPY | 359.08% |
2013 Q1 | 32.57 Million JPY | -24.13% |
2013 FY | - JPY | 11.48% |
2012 Q3 | 439.72 Million JPY | 196.97% |
2012 FY | - JPY | -2.16% |
2012 Q1 | 68.5 Million JPY | -42.74% |
2012 Q4 | 42.93 Million JPY | -90.24% |
2012 Q2 | 148.06 Million JPY | 116.13% |
2011 FY | - JPY | -6.74% |
2011 Q2 | 245.02 Million JPY | 234.56% |
2011 Q3 | 564.16 Million JPY | 130.25% |
2011 Q4 | 119.64 Million JPY | -78.79% |
2011 Q1 | 73.23 Million JPY | -57.3% |
2010 Q4 | 171.52 Million JPY | -73.52% |
2010 FY | - JPY | -2.25% |
2010 Q3 | 647.72 Million JPY | 162.73% |
2010 Q2 | 246.54 Million JPY | 59.3% |
2010 Q1 | 154.76 Million JPY | -51.32% |
2009 Q3 | 592.18 Million JPY | 128.17% |
2009 FY | - JPY | 8.03% |
2009 Q1 | 79.05 Million JPY | -65.93% |
2009 Q4 | 317.9 Million JPY | -46.32% |
2009 Q2 | 259.54 Million JPY | 228.29% |
2008 FY | - JPY | 12.63% |
2008 Q2 | 192.17 Million JPY | 0.0% |
2008 Q4 | 232.03 Million JPY | -62.01% |
2008 Q3 | 610.73 Million JPY | 217.8% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | -42.859% |
Euglena Co., Ltd. | 676 Million JPY | -235.572% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | -15.454% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -308.176% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 43.472% |
Kao Corporation | 154.49 Billion JPY | 98.532% |
Niitaka Co., Ltd. | 1.36 Billion JPY | -65.639% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 95.357% |
Shiseido Company, Limited | 106.46 Billion JPY | 97.869% |
Lion Corporation | 42.31 Billion JPY | 94.639% |
Mandom Corporation | 6.69 Billion JPY | 66.137% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -835.065% |
Milbon Co., Ltd. | 7.8 Billion JPY | 70.919% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -76.045% |
Fancl Corporation | 16.6 Billion JPY | 86.337% |
KOSÉ Corporation | 26.85 Billion JPY | 91.554% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 272.598% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -1220.051% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 90.212% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 81.473% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -1729.41% |
Almado, Inc. | 983.21 Million JPY | -130.719% |
I-ne CO., LTD. | 4.7 Billion JPY | 51.735% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 461.797% |
Liberta Co.,Ltd. | 318.19 Million JPY | -612.924% |
AXXZIA Inc. | 1.28 Billion JPY | -76.328% |
S.T. Corporation | 2.62 Billion JPY | 13.615% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 92.84% |
Earth Corporation | 10.6 Billion JPY | 78.615% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -107.252% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 495.217% |
Ya-Man Ltd. | 1.43 Billion JPY | -57.887% |
MTG Co., Ltd. | 4.39 Billion JPY | 48.374% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 60.951% |
SHOBIDO Corporation | 1.11 Billion JPY | -104.33% |
Artnature Inc. | 3.78 Billion JPY | 40.099% |
Pigeon Corporation | 15.8 Billion JPY | 85.648% |
Unicharm Corporation | 178.01 Billion JPY | 98.726% |
Paltac Corporation | 35.92 Billion JPY | 93.685% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | 30.945% |